Title:
Clofazimine in vitiligo

dc.contributor.authorP.K. Guha
dc.contributor.authorS.S. Pandey
dc.contributor.authorG. Singh
dc.date.accessioned2026-02-09T10:33:04Z
dc.date.issued1980
dc.description.abstract11 patients with vitiligo were treated with Clofazimine, for a period of 3 months. There was no evidence of repigmentation of the affected areas in any of the patients treated. Exposure to sunlight in addition, did not improve the response.
dc.identifier.issn3786323
dc.identifier.urihttps://dl.bhu.ac.in/bhuir/handle/123456789/58601
dc.titleClofazimine in vitiligo
dc.typePublication
dspace.entity.typeArticle

Files

Collections